SG Americas Securities LLC Makes New Investment in Liquidia Technologies, Inc. (NASDAQ:LQDA)

SG Americas Securities LLC purchased a new stake in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 61,735 shares of the company's stock, valued at approximately $911,000. SG Americas Securities LLC owned 0.07% of Liquidia Technologies as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. GAMMA Investing LLC increased its position in shares of Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after acquiring an additional 1,173 shares during the period. Steward Partners Investment Advisory LLC bought a new stake in shares of Liquidia Technologies in the fourth quarter worth about $59,000. Summit Investment Advisors Inc. increased its holdings in Liquidia Technologies by 35.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock valued at $78,000 after purchasing an additional 1,719 shares during the period. D. E. Shaw & Co. Inc. purchased a new position in Liquidia Technologies during the 4th quarter valued at about $142,000. Finally, EntryPoint Capital LLC bought a new position in Liquidia Technologies during the 4th quarter valued at approximately $154,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Insider Buying and Selling at Liquidia Technologies

In other news, General Counsel Russell Schundler sold 5,964 shares of the business's stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $80,931.48. Following the sale, the general counsel now directly owns 570,301 shares of the company's stock, valued at $7,738,984.57. The trade was a 1.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Roger Jeffs sold 14,130 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the transaction, the chief executive officer now directly owns 1,006,420 shares of the company's stock, valued at approximately $13,657,119.40. This trade represents a 1.38% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,138 shares of company stock valued at $450,233. Corporate insiders own 26.50% of the company's stock.

Liquidia Technologies Stock Down 3.4%

Liquidia Technologies stock traded down $0.47 on Friday, hitting $13.17. 1,905,125 shares of the stock traded hands, compared to its average volume of 1,216,406. Liquidia Technologies, Inc. has a 1 year low of $8.26 and a 1 year high of $19.41. The firm has a market cap of $1.13 billion, a P/E ratio of -8.34 and a beta of 0.04. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. The business's fifty day simple moving average is $15.26 and its 200 day simple moving average is $14.22.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($0.03). Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. The business had revenue of $3.12 million during the quarter, compared to the consensus estimate of $3.23 million. As a group, sell-side analysts forecast that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Analyst Upgrades and Downgrades

LQDA has been the topic of a number of recent analyst reports. Scotiabank lifted their price objective on Liquidia Technologies from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a research report on Wednesday, May 28th. Raymond James Financial lifted their price target on shares of Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a report on Friday, May 9th. Oppenheimer set a $13.00 price objective on shares of Liquidia Technologies and gave the company an "underperform" rating in a research report on Monday, May 19th. HC Wainwright raised their target price on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a research report on Wednesday, May 28th. Finally, Wells Fargo & Company lifted their target price on shares of Liquidia Technologies from $23.00 to $25.00 and gave the company an "overweight" rating in a research note on Thursday, June 12th. One analyst has rated the stock with a sell rating, one has given a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.89.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).